Relationship between age at menarche and breast cancer in individuals, as well as in first-degree kin and estrogen receptor status: a Mendelian randomization study
- PMID: 38947899
- PMCID: PMC11211530
- DOI: 10.3389/fonc.2024.1408132
Relationship between age at menarche and breast cancer in individuals, as well as in first-degree kin and estrogen receptor status: a Mendelian randomization study
Abstract
Target: We executed a Mendelian randomization (MR) investigation employing two distinct cohorts of genetic instrumental variables to elucidate the causal nexus between age at menarche (AAM) and the incidence of disparate breast cancer (BC) subtypes, in addition to the incidence of BC among first-degree kin.
Methods: We aggregated statistical data pertaining to AAM and BC from various consortia representing a homogenous population cohort. MR analysis was conducted employing inverse variance weighted (IVW) methodology as the principal approach, complemented by weighted median and MR-Egger regression techniques for an exhaustive evaluation. To evaluate the presence of pleiotropy, we applied the MR-Egger intercept test, MR-PRESSO, and leave-one-out sensitivity analysis.
Results: Upon exclusion of confounding SNP, an increment of one standard deviation in AAM was inversely correlated with the incidence of BC. (odds ratio [OR] 0.896, 95% confidence interval [CI] 0.831-0.968)/(OR 0.998, 95% CI 0.996-0.999) and estrogen receptor-positive (ER+) BC incidence (OR 0.895, 95% CI 0.814-0.983). It was also associated with reducing the risk of maternal BC incidence (OR 0.995, 95% CI 0.990-0.999) and sibling BC incidence (OR 0.997, 95% CI 0.994-0.999). No significant association was found between AAM and estrogen receptor-negative (ER-) BC incidence (OR 0.936, 95% CI 0.845-1.037).
Conclusion: Our study substantiated the causal relationship between a delayed AAM and a diminished risk of BC in probands, as well as in their maternal progenitors and siblings. Furthermore, the analysis suggests that AAM exerts a considerable potential causal influence on the risk of developing Luminal-a/b subtype of BC.
Keywords: Mendelian randomization study; age at menarche; breast cancer; estrogen receptor; first-degree relatives.
Copyright © 2024 Zhao, Zhang and Tian.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Skimmed milk intake reduces the risk of ER- breast cancer: a Mendelian randomization analysis.Discov Oncol. 2024 Nov 2;15(1):612. doi: 10.1007/s12672-024-01448-5. Discov Oncol. 2024. PMID: 39487869 Free PMC article.
-
Mendelian randomization study and meta-analysis exploring the causality of age at menarche and the risk of intracerebral hemorrhage and ischemic stroke.CNS Neurosci Ther. 2023 Oct;29(10):3043-3052. doi: 10.1111/cns.14245. Epub 2023 May 11. CNS Neurosci Ther. 2023. PMID: 37170723 Free PMC article.
-
Age at menarche and idiopathic pulmonary fibrosis: a two-sample mendelian randomization study.BMC Pulm Med. 2024 Mar 6;24(1):117. doi: 10.1186/s12890-024-02936-8. BMC Pulm Med. 2024. PMID: 38448907 Free PMC article.
-
Genetic causal relationship between age at menarche and benign oesophageal neoplasia identified by a Mendelian randomization study.Front Endocrinol (Lausanne). 2023 Mar 21;14:1113765. doi: 10.3389/fendo.2023.1113765. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37025412 Free PMC article.
-
Relationship between oily fish intake and breast cancer based on estrogen receptor status: a Mendelian randomization study.Breast Cancer Res Treat. 2024 Jan;203(1):145-152. doi: 10.1007/s10549-023-07130-8. Epub 2023 Oct 3. Breast Cancer Res Treat. 2024. PMID: 37787818
References
Grants and funding
LinkOut - more resources
Full Text Sources